Search results
IDEAYA Biosciences Inc (IDYA) Reports Q1 2024 Earnings: Financia
Guru Focus· 5 days agoOn May 7, 2024, IDEAYA Biosciences Inc (IDYA, Financial) released its 8-K filing, announcing the financial results for the first quarter ended March 31, 2024. The precision medicine oncology ...
What's Going With Moderna Stock On Friday? - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoThe Food and Drug Administration (FDA) notified Moderna Inc MRNA on Friday that its review of a new vaccine has been delayed. The agency, citing administrative constraints ...
Four ways the vaccine rush will define infectious disease trends for CROs in 2024
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe speed and flexibility required in clinical trials for COVID-19 set a new precedent for what can...
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 15 hours agoProtalix BioTherapeutics, Inc. (AMEX:PLX) Q1 2024 Earnings Call Transcript May 10, 2024 Protalix...
OPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoOPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript May 7, 2024 OPKO Health, Inc. misses...
Q1 2024 OPKO Health Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 days agoMoving to our pharmaceutical pharmaceutical segment, as you've heard and Jamba has been launched in all major global markets by Pfizer. We believe this drug is well positioned ...
Opko Health (OPK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 4 days agoAs an ongoing initiative, we continue to improve BioReference's performance and in turn build value. Our focus...As you know, the 4Kscore Test was first...
GlycoMimetics fails phase 3 blood cancer trial, causing investors to sour on stock
FierceBiotech· 6 days agoGlycoMimetics CEO Harout Semerjian told investors in March that phase 3 blood cancer results could “fundamentally impact our company's trajectory.” Monday, GlycoMimetics reported the failure ...
GSK, Boehringer Put Profits Over User Safety, Zantac Jury Told
Insurance Journal· 6 days agoDrugmakers GSK Plc and Boehringer Ingelheim GmbH prioritized profits over consumer safety by hiding...
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
Morningstar· 4 days agoMIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2024. First quarter business highlights include the following: Entered into an agreement
